Effects of Continuous Glucose Monitoring Versus Blood Glucose Monitoring During a Carbohydrate-Restricted Nutrition Intervention in People With Type 2 Diabetes: 6-Month Follow-up Outcomes From a Randomized Clinical Trial
Authors' conclusion
The CGM and BGM arms achieved similar and significant improvements in glycemia and other diabetes-related outcomes after 6 months in this MSKDP.
Study context
- Population
- Adults with T2D; mean (SD) T2D duration 9.7 (7.7) years, HbA1c 8.1% (1.2%)
- Participants
- 163 adults
- Comparison
- Continuous glucose monitoring (CGM) vs blood glucose monitoring (BGM) during a virtual medically supervised ketogenic diet program
- CGMn = 81
- BGMn = 82reference
Primary result
As reported in the abstract
TIR · Base to M6
- Within-arm improvement
- P < .001
Further findings
HbA1c · baseline (Base) to M6
- HbA1c decreased at least 1.3% in both arms
- P < 0.001
Diabetes medications · Base to M6
- Deintensified in both arms based on medication effect scores
- P < 0.01
Energy and carbohydrate intake · Base to M6
- Energy and carbohydrate intake decreased
- P < 0.001
Weight · Base to M6
- Clinically meaningful weight loss in both arms
- P < 0.001
Original publication
Effects of Continuous Glucose Monitoring Versus Blood Glucose Monitoring During a Carbohydrate-Restricted Nutrition Intervention in People With Type 2 Diabetes: 6-Month Follow-up Outcomes From a Randomized Clinical Trial. Endocr Pract. Published 2 June 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →